Results 261 to 270 of about 286,346 (314)

Serum cholesterol and HDL cholesterol in childhood

Irish Journal of Medical Science, 1981
Serum concentrations of total cholesterol and of HDL cholesterol have been measured in 170 Irish children, aged 1–12 years, attending hospital for conditions other than hyperlipidaemia. There were no significant differences between the sexes, or between fasting and non-fasting samples for either estimation.
D A, Kelly, H, Hooey, G, Neale, A R, McGill, M, Stuart   +4 more
openaire   +2 more sources

From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants

Current Opinion in Lipidology, 2019
Purpose of review The validity of HDL-cholesterol (HDL-C) elevation as a therapeutic target has been questioned, in comparison to enhancing HDL functionality. Cholesterol efflux capacity (CEC) is an in-vitro assay that measures the ability of an individual's HDL to promote cholesterol efflux from cholesterol donor cells such as
David, Rhainds, Jean-Claude, Tardif
openaire   +2 more sources

Thiazolidinediones and Lowered HDL Cholesterol

Diabetes Care, 2005
Three publications, including two recently in Diabetes Care, have indicated that a combination of rosiglitazone and fibrates may lower serum HDL cholesterol in some patients (1–3). It is known that a paradoxical fall in HDL cholesterol may occur with fibrates.
Ruth L, Savage, Anne, Kiuru
openaire   +2 more sources

Plasma HDL cholesterol and the in vitro esteriflcation of cholesterol

Scandinavian Journal of Clinical and Laboratory Investigation, 1979
In vitro esterification of plasma cholesterol was measured in twelve healthy subjects, six of whom had high plasma concentrations of high density lipoprotein (HDL) cholesterol, whereas the other six had low concentrations. Irrespective of the method used no difference between the groups with the respect to cholesterol esterification could be ...
K T, Stokke, S C, Enger
openaire   +2 more sources

Increasing HDL Cholesterol Levels

New England Journal of Medicine, 2004
In the past decade, high-density lipoproteins (HDL) have emerged as a new potential therapeutic target for the treatment of cardiovascular disease. The key role of HDL as a carrier of excess cellular cholesterol in the reverse cholesterol transport pathway is believed to provide protection against atherosclerosis.
openaire   +2 more sources

Determinants of HDL-Cholesterol and the HDL-Cholesterol/Total Cholesterol Ratio. Results of the Lübeck Blood Pressure Study

International Journal of Epidemiology, 1990
Results are presented here on the relationship, in a large city in the Federal Republic of Germany, between HDL-cholesterol (HDL-C) or the HDL-cholesterol/total cholesterol ratio (HDL-C/TC) and the variables smoking, alcohol consumption, Body Mass Index (BMI), and age.
L, Chambless, A, Döring, B, Filipiak, U, Keil   +3 more
openaire   +2 more sources

HDL-Cholesterol Levels in Gouty Patients

1984
Lipoprotein abnormalities are common in gout. The most frequent is hypertriglyceridemia, which has been reported in three-quarters of patients with primary gout (1, 2). This alteration may or may not be related to obesity, alcohol consumption, and glucose intolerance (3). Patients with gout secondary to lead nephropathy do not have hypertriglyceridemia
Carcassi, A., Boschi, S., Macri, P., Mondillo, S.   +3 more
openaire   +4 more sources

Why is HDL‐cholesterol good cholesterol?

Lipid Technology, 2008
AbstractThe well recognized ability of high density lipoprotein (HDL) cholesterol, sometimes called good cholesterol, to protect against the risk of developing of cardiovascular disease requires an explanation. Such an explanation may be the role that HDL plays in the process of reverse cholesterol transport as practised by cells of the arterial wall ...
openaire   +1 more source

The complexity of the role of HDL-cholesterol

Revista Española de Cardiología (English Edition), 2023
Carlos, Brotons, Irene, Moral, Johanna, Vicuña   +2 more
openaire   +2 more sources

[HDL cholesterol].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Hideo, Kanehara, Koji, Oida
openaire   +3 more sources